Across all tumour types, oncogenes in the RTK–RAS (EGFR, ERBB2 and FGFR1), TP53 (MDM2) and cell cycle (CCND1 and CDK4) pathways were most commonly amplified on ecDNA (Extended Data Fig. 8b). This evidence concerns the gene MDM2 and neoplasm.